Basic Information
Basic information for C5orf64-221-11aa-1
Peptide Name C5orf64-221-11aa-1
Genome Position chr5:61793135-61793167[+]
Species Human
Peptide Sequence MCSHCSTPTYE
Peptide Length 11
Unique No (LINC00507-201-11aa-2,LINC00507-202-11aa-2,AC007848.2-201-11aa-1,LINC00507-203-11aa-2,AC006213.6-201-11aa-3,LINC00507-204-11aa-3,LINC00507-205-11aa-2,LINC00507-206-11aa-3,LINC00507-207-11aa-2,LINC00507-208-11aa-2,LINC00507-209-11aa-2,LINC00507-211-11aa-2,LINC00507-212-11aa-2,LINC00507-213-11aa-3,LINC00507-214-11aa-3,LINC00507-215-11aa-2,LINC02840-209-11aa-1,LINC00507-218-11aa-3,LINC00507-220-11aa-3,LINC00507-222-11aa-3,LINC02840-214-11aa-2,LINC02254-213-11aa-1)
Grand Average of Hydropathicity -0.5182
Relative Molecular Mass 1438.64
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000178722;C5orf64
Transcript ID/Name ENST00000667197;C5orf64-221
Transcript Length 3441
Coding Ability 0.3726
DNA Sequence Corresponding to Peptide ATGTGTTCTCATTGTTCAACTCCCACTTATGAG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :